Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 2/20 | 0.46 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.40 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 3/20 | 0.37 |
| ▸ | BCHE | P06276 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL524603 | 0.73 | GPR3 (0.50) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL29950614 | 0.73 | GPR3 (0.50) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL1107108 | 0.71 | GPR3 (0.48) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL825558 | 0.71 | HTR2A (0.55) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL9179507 | 0.69 | HTR2A (0.52) | HTR2A | |
| SCHEMBL19973035 | 0.69 | GPR3 (0.41) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL4989863 | 0.69 | HTR2A (0.58) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL6550865 | 0.69 | GPR3 (0.41) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL40598 | 0.69 | GPR3 (0.46) | GPR3HTR2ASLC22A2SLC22A3HDAC3 | |
| SCHEMBL353865 | 0.69 | HTR2A (0.52) | GPR3HTR2AHDAC3HDAC4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107428639-B | Double-spiro compound and organic light-emitting element comprising same | 株式会社LG化学 | 2020-10-30 | — | — | CN | claimed |
| CN-117986281-A | Boron-containing condensed ring aromatic compound and preparation method and application thereof | 深圳大学 | 2024-05-07 | — | — | CN | disclosed |
| US-11930703-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, display device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-03-12 | — | — | US | disclosed |
| CN-117598046-A | Organic electroluminescent element | 保土谷化学工业株式会社 | 2024-02-23 | — | — | CN | disclosed |
| CN-113227108-B | Compound and organic light emitting diode comprising the same | 株式会社LG化学 | 2024-02-02 | — | — | CN | disclosed |
| CN-113214202-B | Heterocyclic compound and organic light emitting diode comprising the same | 株式会社LG化学 | 2023-11-21 | — | — | CN | disclosed |
| US-20230345817-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| CN-113056468-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-09-01 | — | — | CN | disclosed |
| CN-116530232-A | Organic electroluminescent element | 保土谷化学工业株式会社 | 2023-08-01 | — | — | CN | disclosed |
| EP-4198104-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2023-06-21 | — | — | EP | disclosed |
| EP-1173438-A1 | SUBSTITUTED IMIDAZOLES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2002-01-23 | — | — | EP | disclosed |
| US-6204260-B1 | 2-(AZETIDIN-2-ON-1-YL)ACETIC ACID DERIVATIVES | ELI LILLY AND COMPANY | 2001-03-20 | — | — | US | disclosed |
| WO-2000063208-A1 | SUBSTITUTED IMIDAZOLES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2000-10-26 | — | — | WO | disclosed |
| EP-0654093-A4 | DETECTING AND AMPLIFYING TARGET NUCLEIC ACIDS USING EXONUCLEOLYTIC ACTIVITY. | ABBOTT LAB (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0808303-A1 | 5-(4-SUBST.-PIPERIDINYL-1)-3-ARYL-PENTANOIC ACID DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONIST | ZENECA LIMITED (GB) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024582-A1 | 5-(4-SUBST.-PIPERIDINYL-1)-3-ARYL-PENTANOIC ACID DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONIST | ZENECA LIMITED (GB) | 1996-08-15 | — | — | WO | disclosed |
| WO-1996015105-A1 | FLUORENYL-HYDROXAMIC DERIVATIVES ENDOWED WITH IMMUNOSUPPRESSIVE AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO S.P.A. (IT) | 1996-05-23 | — | — | WO | disclosed |
| WO-1996015105-A1 | FLUORENYL-HYDROXAMIC DERIVATIVES ENDOWED WITH IMMUNOSUPPRESSIVE AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO S.P.A. (IT) | 1996-05-23 | — | — | WO | disclosed |
| EP-0654093-A1 | DETECTING AND AMPLIFYING TARGET NUCLEIC ACIDS USING EXONUCLEOLYTIC ACTIVITY | ABBOTT LABORATORIES (US) | 1995-05-24 | — | — | EP | disclosed |
| WO-1994003636-A1 | DETECTING AND AMPLIFYING TARGET NUCLEIC ACIDS USING EXONUCLEOLYTIC ACTIVITY | ABBOTT LABORATORIES (US) | 1994-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11930703-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, display device, and lighting device | TRPA1, SLCO2A1, TYR | GPR3 2890/4885HTR2A 1096/4885SLC22A2 168/4885 |
| US-20230345817-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SLC7A5, SLC43A1, SLCO4C1 | GPR3 4086/4885HTR2A 435/4885SLC22A2 143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.